PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, which is intended to treat chronic and acute wounds, today announced that the financial results for its fiscal second quarter ended September 30, 2009, will be released after the U.S. market closes on November 5, 2009. The earnings release will be followed by a conference call at 1:30 p.m. PT (4:30 p.m. ET) on November 5, 2009, to discuss fiscal second quarter results and provide a corporate update to the investment community.
